Tscan Therapeutics Inc (TCRX) Insider Trading
- $3,701,850.02
- $1,015,893.08
- May 20, 2025
- Lynx1 Capital Management Lp
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 20, 2025 | Major Shareholder | 1,200,000 | $1.20 | Buy | $1,440,000.00 | |
| May 19, 2025 | Major Shareholder | 1,388,794 | $1.20 | Buy | $1,666,552.80 | |
| Nov. 15, 2024 | Major Shareholder | 947 | $4.34 | Buy | $4,109.98 | |
| Sept. 23, 2024 | Director | 5,000 | $5.29 | Buy | $26,450.00 | |
| Aug. 26, 2024 | Director | 5,000 | $5.53 | Buy | $27,650.00 | |
| Aug. 23, 2024 | Insider | 164,686 | $5.78 | Sell | $951,885.08 | |
| Aug. 23, 2024 | Director | 5,000 | $5.69 | Buy | $28,450.00 | |
| Dec. 18, 2023 | Director | 28,830 | $4.89 | Buy | $140,978.70 | |
| Dec. 14, 2023 | Director | 5,000 | $5.08 | Buy | $25,400.00 | |
| June 2, 2023 | Director | 37,880 | $2.63 | Buy | $99,624.40 | |
| May 31, 2023 | Major Shareholder | 25,400 | $2.52 | Sell | $64,008.00 | |
| Dec. 27, 2022 | CFO | 2,842 | $1.50 | Buy | $4,263.00 | |
| May 18, 2022 | CEO | 25,000 | $3.59 | Buy | $89,750.00 | |
| March 24, 2022 | CFO | 15,000 | $3.40 | Buy | $51,000.00 | |
| Sept. 23, 2021 | Insider | 4,716 | $7.48 | Buy | $35,275.68 | |
| Sept. 21, 2021 | CFO | 5,000 | $6.32 | Buy | $31,600.00 | |
| Sept. 20, 2021 | Insider | 4,943 | $6.22 | Buy | $30,745.46 |
Insiders are both buying and selling Tscan Therapeutics Inc stock.
The insider traders at Tscan Therapeutics Inc are: Barbara Klencke, Lynx1 Capital Management Lp, Brian M Silver, Timothy J Barberich, Zoran Zdraveski, Gavin Macbeath, and David P Southwell
The most active insider trader at Tscan Therapeutics Inc is Barbara Klencke with 4 trades.
Zoran Zdraveski has sold the most Tscan Therapeutics Inc stock with a total value of $1,903,770.16.
Lynx1 Capital Management Lp has bought the most Tscan Therapeutics Inc stock with a total value of $4,550,662.78.
The most recent insider trade for Tscan Therapeutics Inc was on May 20, 2025.
The single biggest insider buy for Tscan Therapeutics Inc was from Lynx1 Capital Management Lp with a total value of $1,666,552.80 on May 19, 2025.
The single biggest insider sell for Tscan Therapeutics Inc was from Zoran Zdraveski with a total value of $951,885.08 on Aug. 23, 2024.